Disease Severity and Prognosis of SARS-CoV-2 Infection in Hospitalized Patients Is Not Associated With Viral Load in Nasopharyngeal Swab

Background: The impact of viral burden on severity and prognosis of patients hospitalized for Coronavirus Disease 2019 (COVID-19) is still a matter of debate due to controversial results. Herein, we sought to assess viral load in the nasopharyngeal swab and its association with severity score indexe...

Full description

Bibliographic Details
Main Authors: Elisabetta Cocconcelli, Gioele Castelli, Francesco Onelia, Enrico Lavezzo, Chiara Giraudo, Nicol Bernardinello, Giulia Fichera, Davide Leoni, Marco Trevenzoli, Marina Saetta, Annamaria Cattelan, Andrea Crisanti, Paolo Spagnolo, Elisabetta Balestro
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.714221/full
id doaj-80d6a2e5d7634aa2bab21ac792bd52b3
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Elisabetta Cocconcelli
Gioele Castelli
Francesco Onelia
Enrico Lavezzo
Chiara Giraudo
Nicol Bernardinello
Giulia Fichera
Davide Leoni
Marco Trevenzoli
Marina Saetta
Annamaria Cattelan
Andrea Crisanti
Paolo Spagnolo
Elisabetta Balestro
spellingShingle Elisabetta Cocconcelli
Gioele Castelli
Francesco Onelia
Enrico Lavezzo
Chiara Giraudo
Nicol Bernardinello
Giulia Fichera
Davide Leoni
Marco Trevenzoli
Marina Saetta
Annamaria Cattelan
Andrea Crisanti
Paolo Spagnolo
Elisabetta Balestro
Disease Severity and Prognosis of SARS-CoV-2 Infection in Hospitalized Patients Is Not Associated With Viral Load in Nasopharyngeal Swab
Frontiers in Medicine
SARS-CoV-2
coronavirus disease 2019
viral load
hospitalized patients
outcome assessment
author_facet Elisabetta Cocconcelli
Gioele Castelli
Francesco Onelia
Enrico Lavezzo
Chiara Giraudo
Nicol Bernardinello
Giulia Fichera
Davide Leoni
Marco Trevenzoli
Marina Saetta
Annamaria Cattelan
Andrea Crisanti
Paolo Spagnolo
Elisabetta Balestro
author_sort Elisabetta Cocconcelli
title Disease Severity and Prognosis of SARS-CoV-2 Infection in Hospitalized Patients Is Not Associated With Viral Load in Nasopharyngeal Swab
title_short Disease Severity and Prognosis of SARS-CoV-2 Infection in Hospitalized Patients Is Not Associated With Viral Load in Nasopharyngeal Swab
title_full Disease Severity and Prognosis of SARS-CoV-2 Infection in Hospitalized Patients Is Not Associated With Viral Load in Nasopharyngeal Swab
title_fullStr Disease Severity and Prognosis of SARS-CoV-2 Infection in Hospitalized Patients Is Not Associated With Viral Load in Nasopharyngeal Swab
title_full_unstemmed Disease Severity and Prognosis of SARS-CoV-2 Infection in Hospitalized Patients Is Not Associated With Viral Load in Nasopharyngeal Swab
title_sort disease severity and prognosis of sars-cov-2 infection in hospitalized patients is not associated with viral load in nasopharyngeal swab
publisher Frontiers Media S.A.
series Frontiers in Medicine
issn 2296-858X
publishDate 2021-09-01
description Background: The impact of viral burden on severity and prognosis of patients hospitalized for Coronavirus Disease 2019 (COVID-19) is still a matter of debate due to controversial results. Herein, we sought to assess viral load in the nasopharyngeal swab and its association with severity score indexes and prognostic parameters.Methods: We included 127 symptomatic patients and 21 asymptomatic subjects with a diagnosis of SARS-CoV-2 infection obtained by reverse transcription polymerase chain reaction and presence of cycle threshold. According to the level of care needed during hospitalization, the population was categorized as high-intensity (HIMC, n = 76) or low intensity medical care setting (LIMC, n = 51).Results: Viral load did not differ among asymptomatic, LIMC, and HIMC SARS-CoV-2 positive patients [4.4 (2.9–5.3) vs. 4.8 (3.6–6.1) vs. 4.6 (3.9–5.7) log10 copies/ml, respectively; p = 0.31]. Similar results were observed when asymptomatic individuals were compared to hospitalized patients [4.4 (2.9–5.3) vs. 4.68 (3.8–5.9) log10 copies/ml; p = 0.13]. When the study population was divided in High (HVL, n = 64) and Low Viral Load (LVL, n = 63) group no differences were observed in disease severity at diagnosis. Furthermore, LVL and HVL groups did not differ with regard to duration of hospital stay, number of bacterial co-infections, need for high-intensity medical care and number of deaths. The viral load was not an independent risk factor for HIMC in an adjusted multivariate regression model (OR: 1.59; 95% CI: 0.46–5.55, p = 0.46).Conclusions: Viral load at diagnosis is similar in asymptomatic and hospitalized patients and is not associated with either worse outcomes during hospitalization. SARS CoV-2 viral load might not be the right tool to assist clinicians in risk-stratifying hospitalized patients.
topic SARS-CoV-2
coronavirus disease 2019
viral load
hospitalized patients
outcome assessment
url https://www.frontiersin.org/articles/10.3389/fmed.2021.714221/full
work_keys_str_mv AT elisabettacocconcelli diseaseseverityandprognosisofsarscov2infectioninhospitalizedpatientsisnotassociatedwithviralloadinnasopharyngealswab
AT gioelecastelli diseaseseverityandprognosisofsarscov2infectioninhospitalizedpatientsisnotassociatedwithviralloadinnasopharyngealswab
AT francescoonelia diseaseseverityandprognosisofsarscov2infectioninhospitalizedpatientsisnotassociatedwithviralloadinnasopharyngealswab
AT enricolavezzo diseaseseverityandprognosisofsarscov2infectioninhospitalizedpatientsisnotassociatedwithviralloadinnasopharyngealswab
AT chiaragiraudo diseaseseverityandprognosisofsarscov2infectioninhospitalizedpatientsisnotassociatedwithviralloadinnasopharyngealswab
AT nicolbernardinello diseaseseverityandprognosisofsarscov2infectioninhospitalizedpatientsisnotassociatedwithviralloadinnasopharyngealswab
AT giuliafichera diseaseseverityandprognosisofsarscov2infectioninhospitalizedpatientsisnotassociatedwithviralloadinnasopharyngealswab
AT davideleoni diseaseseverityandprognosisofsarscov2infectioninhospitalizedpatientsisnotassociatedwithviralloadinnasopharyngealswab
AT marcotrevenzoli diseaseseverityandprognosisofsarscov2infectioninhospitalizedpatientsisnotassociatedwithviralloadinnasopharyngealswab
AT marinasaetta diseaseseverityandprognosisofsarscov2infectioninhospitalizedpatientsisnotassociatedwithviralloadinnasopharyngealswab
AT annamariacattelan diseaseseverityandprognosisofsarscov2infectioninhospitalizedpatientsisnotassociatedwithviralloadinnasopharyngealswab
AT andreacrisanti diseaseseverityandprognosisofsarscov2infectioninhospitalizedpatientsisnotassociatedwithviralloadinnasopharyngealswab
AT paolospagnolo diseaseseverityandprognosisofsarscov2infectioninhospitalizedpatientsisnotassociatedwithviralloadinnasopharyngealswab
AT elisabettabalestro diseaseseverityandprognosisofsarscov2infectioninhospitalizedpatientsisnotassociatedwithviralloadinnasopharyngealswab
_version_ 1717758741911175168
spelling doaj-80d6a2e5d7634aa2bab21ac792bd52b32021-09-10T04:23:17ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2021-09-01810.3389/fmed.2021.714221714221Disease Severity and Prognosis of SARS-CoV-2 Infection in Hospitalized Patients Is Not Associated With Viral Load in Nasopharyngeal SwabElisabetta Cocconcelli0Gioele Castelli1Francesco Onelia2Enrico Lavezzo3Chiara Giraudo4Nicol Bernardinello5Giulia Fichera6Davide Leoni7Marco Trevenzoli8Marina Saetta9Annamaria Cattelan10Andrea Crisanti11Paolo Spagnolo12Elisabetta Balestro13Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova and Padova City Hospital, Padova, ItalyDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova and Padova City Hospital, Padova, ItalyDepartment of Molecular Medicine, University of Padova and Padova City Hospital, Padova, ItalyDepartment of Molecular Medicine, University of Padova and Padova City Hospital, Padova, ItalyDepartment of Medicine, Institute of Radiology, University of Padova and Padova City Hospital, Padova, ItalyDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova and Padova City Hospital, Padova, ItalyDepartment of Medicine, Institute of Radiology, University of Padova and Padova City Hospital, Padova, ItalyDivision of Infectious and Tropical Diseases, University of Padova and Padova City Hospital, Padova, ItalyDivision of Infectious and Tropical Diseases, University of Padova and Padova City Hospital, Padova, ItalyDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova and Padova City Hospital, Padova, ItalyDivision of Infectious and Tropical Diseases, University of Padova and Padova City Hospital, Padova, ItalyDepartment of Molecular Medicine, University of Padova and Padova City Hospital, Padova, ItalyDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova and Padova City Hospital, Padova, ItalyDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova and Padova City Hospital, Padova, ItalyBackground: The impact of viral burden on severity and prognosis of patients hospitalized for Coronavirus Disease 2019 (COVID-19) is still a matter of debate due to controversial results. Herein, we sought to assess viral load in the nasopharyngeal swab and its association with severity score indexes and prognostic parameters.Methods: We included 127 symptomatic patients and 21 asymptomatic subjects with a diagnosis of SARS-CoV-2 infection obtained by reverse transcription polymerase chain reaction and presence of cycle threshold. According to the level of care needed during hospitalization, the population was categorized as high-intensity (HIMC, n = 76) or low intensity medical care setting (LIMC, n = 51).Results: Viral load did not differ among asymptomatic, LIMC, and HIMC SARS-CoV-2 positive patients [4.4 (2.9–5.3) vs. 4.8 (3.6–6.1) vs. 4.6 (3.9–5.7) log10 copies/ml, respectively; p = 0.31]. Similar results were observed when asymptomatic individuals were compared to hospitalized patients [4.4 (2.9–5.3) vs. 4.68 (3.8–5.9) log10 copies/ml; p = 0.13]. When the study population was divided in High (HVL, n = 64) and Low Viral Load (LVL, n = 63) group no differences were observed in disease severity at diagnosis. Furthermore, LVL and HVL groups did not differ with regard to duration of hospital stay, number of bacterial co-infections, need for high-intensity medical care and number of deaths. The viral load was not an independent risk factor for HIMC in an adjusted multivariate regression model (OR: 1.59; 95% CI: 0.46–5.55, p = 0.46).Conclusions: Viral load at diagnosis is similar in asymptomatic and hospitalized patients and is not associated with either worse outcomes during hospitalization. SARS CoV-2 viral load might not be the right tool to assist clinicians in risk-stratifying hospitalized patients.https://www.frontiersin.org/articles/10.3389/fmed.2021.714221/fullSARS-CoV-2coronavirus disease 2019viral loadhospitalized patientsoutcome assessment